Skip to main content
. 2018 Jul 5;17(10):1188–1198. doi: 10.1080/15384101.2018.1467675

Figure 3.

Figure 3.

LSINCT5 advances migration and viability in vitro. (A) Transwell migration assay for 95C cells transfected with either pcDNA3.1 (pcDNA) or pcDNA-LSINCT5. (B) Transwell migration assay for 95D cells transfected with either si-NC or si-LSINCT5. (C) Transwell migration assay for H838 cells transfected with either pcDNA3.1 (pcDNA) or pcDNA-LSINCT5. (D) Transwell migration assay for A549 cells transfected with either si-NC or si-LSINCT5. Quantification results were shown at bottom in panels (A-D). **: P < 0.01. CCK-8 viability assays for 95C (E), 95D (F), H838 (G) and A549 (H) cells. **: P < 0.01. 95C and H838 cells were transfected with either pcDNA or pcDNA-LSINCT5. 95D and A549 cells were treated with either si-NC or si-LSINCT5 as indicated.